Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Nephritis | 1 | 2023 | 310 | 0.690 |
Why?
|
Neoadjuvant Therapy | 2 | 2020 | 2728 | 0.670 |
Why?
|
Arthroplasty, Replacement, Knee | 6 | 2018 | 1458 | 0.540 |
Why?
|
Preoperative Period | 1 | 2016 | 549 | 0.480 |
Why?
|
Osteoarthritis, Knee | 6 | 2018 | 1222 | 0.420 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2023 | 2104 | 0.370 |
Why?
|
Exercise | 4 | 2019 | 5615 | 0.370 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2418 | 0.290 |
Why?
|
Body Mass Index | 3 | 2020 | 12720 | 0.260 |
Why?
|
Patient Selection | 1 | 2016 | 4215 | 0.240 |
Why?
|
Breast Neoplasms | 3 | 2020 | 20822 | 0.240 |
Why?
|
Pain | 2 | 2016 | 4986 | 0.210 |
Why?
|
Pain Measurement | 3 | 2016 | 3420 | 0.160 |
Why?
|
Prednisone | 1 | 2023 | 1574 | 0.160 |
Why?
|
Receptors, Interleukin-15 | 1 | 2015 | 16 | 0.140 |
Why?
|
Catastrophization | 2 | 2016 | 316 | 0.130 |
Why?
|
Interleukin-15 | 1 | 2015 | 184 | 0.130 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 973 | 0.120 |
Why?
|
Coated Materials, Biocompatible | 1 | 2015 | 319 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2023 | 2107 | 0.110 |
Why?
|
Drugs, Generic | 1 | 2018 | 421 | 0.110 |
Why?
|
Arthralgia | 1 | 2015 | 456 | 0.100 |
Why?
|
Menopause | 1 | 2019 | 1626 | 0.100 |
Why?
|
Occupational Health | 1 | 2017 | 809 | 0.100 |
Why?
|
Self Report | 2 | 2019 | 3558 | 0.100 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1276 | 0.090 |
Why?
|
Recovery of Function | 2 | 2017 | 2925 | 0.090 |
Why?
|
Cohort Studies | 3 | 2023 | 40561 | 0.090 |
Why?
|
Drug Costs | 1 | 2018 | 1105 | 0.090 |
Why?
|
Antigen Presentation | 1 | 2015 | 1284 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1486 | 0.090 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1607 | 0.090 |
Why?
|
Aged | 10 | 2020 | 163280 | 0.080 |
Why?
|
Retrospective Studies | 3 | 2023 | 77449 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2015 | 1988 | 0.080 |
Why?
|
Quality of Life | 3 | 2018 | 12804 | 0.080 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11031 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2017 | 1643 | 0.080 |
Why?
|
Middle Aged | 11 | 2020 | 213383 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2020 | 63114 | 0.070 |
Why?
|
Kidney | 1 | 2023 | 7186 | 0.070 |
Why?
|
Weight Loss | 1 | 2018 | 2622 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3966 | 0.070 |
Why?
|
Adult | 7 | 2023 | 214055 | 0.070 |
Why?
|
Health Promotion | 1 | 2017 | 2205 | 0.070 |
Why?
|
Obesity | 2 | 2017 | 12745 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2015 | 2725 | 0.060 |
Why?
|
Computer Simulation | 1 | 2018 | 6196 | 0.060 |
Why?
|
Nanoparticles | 1 | 2015 | 1905 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13408 | 0.060 |
Why?
|
Female | 12 | 2020 | 380194 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4479 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.050 |
Why?
|
Humans | 14 | 2023 | 744343 | 0.050 |
Why?
|
Mental Health | 1 | 2015 | 3019 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.050 |
Why?
|
Reward | 2 | 2018 | 941 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11524 | 0.040 |
Why?
|
Motivation | 2 | 2018 | 1971 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2018 | 2266 | 0.040 |
Why?
|
New Zealand | 1 | 2017 | 355 | 0.040 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2759 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2016 | 513 | 0.030 |
Why?
|
Male | 9 | 2018 | 350118 | 0.030 |
Why?
|
Telomere | 1 | 2018 | 910 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1405 | 0.020 |
Why?
|
Survivors | 1 | 2018 | 2291 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5078 | 0.020 |
Why?
|
Preoperative Care | 1 | 2016 | 2250 | 0.020 |
Why?
|
Health Behavior | 1 | 2018 | 2636 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5952 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5391 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3396 | 0.020 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Prospective Studies | 2 | 2016 | 53288 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15540 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29063 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57776 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81183 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 72290 | 0.010 |
Why?
|
Animals | 1 | 2015 | 168757 | 0.000 |
Why?
|
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_